New Results

“Amantadine disrupts lysosomal gene expression; potential therapy for COVID19”

Sandra P. Smieszek, Bart P Przychodzen, Mihael H Polymeropoulos
doi: https://doi.org/10.1101/2020.04.05.026187

Article Information

doi 
https://doi.org/10.1101/2020.04.05.026187
History 
  • April 5, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Sandra P. Smieszek, Ph.D1,*,
  2. Bart P Przychodzen1 and
  3. Mihael H Polymeropoulos, MD1
  1. 1Vanda Pharmaceuticals, 2200 Pennsylvania NW, Suite 300-E, Washington, DC 20037
  1. ↵*Corresponding author; email: sps92{at}case.edu
Back to top
Posted April 05, 2020.
Download PDF
Email
“Amantadine disrupts lysosomal gene expression; potential therapy for COVID19”
Sandra P. Smieszek, Bart P Przychodzen, Mihael H Polymeropoulos
bioRxiv 2020.04.05.026187; doi: https://doi.org/10.1101/2020.04.05.026187
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools

Subject Area